Cite
HARVARD Citation
De, A. et al. (2022). Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis. Nephrology. 27 (1), pp. 82-89. [Online].